| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $5K | +0.0% | +0.0% |
| R&D Expense | $15.0M | -13.2% | -24.5% |
| SG&A Expense | $5.9M | +3.7% | +18.8% |
| Operating Income | -$20.9M | +9.0% | +15.8% |
| Pre-tax Income | -$19.0M | +14.1% | +16.8% |
| Income Tax | -$681K | — | — |
| Net Income | -$19.0M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $61.2M | -66.6% | +94.6% |
| Short-term Investments | $149.5M | — | +38.6% |
| Accounts Receivable | $845K | +163.2% | +97.4% |
| Current Assets | $216.6M | +15.0% | +48.6% |
| Total Assets | $218.4M | +14.8% | +47.7% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$48.1M | — | — |
| Capital Expenditures | $10K | — | — |
| Investing Cash Flow | -$53.3M | — | — |
| Financing Cash Flow | $125.7M | — | — |
| Free Cash Flow | -$48.1M | — | — |
| +16.8% |
| EPS (Basic) | -$0.21 | +22.2% | +34.4% |
| EPS (Diluted) | -$0.21 | +22.2% | +34.4% |
| $12.6M |
| +36.7% |
| +45.9% |
| Long-term Debt | $14.4M | +0.8% | — |
| Total Liabilities | $32.8M | +13.3% | +126.7% |
| Stockholders' Equity | $185.6M | +15.0% | +39.2% |